Latest Breaking News On - International biotechnology trust - Page 4 : comparemela.com

Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]

United statesPiper sandlerFrederickm hudsonFrank mottolaSecurities exchange commissionCampbell newman asset management incAssetmark incInternational biotechnology trustBurney coQuarter for supernus pharmaceuticalsSupernus pharmaceuticals stock performanceSupernus pharmaceuticals incDimensional fund advisorsSupernus pharmaceuticals profileExchange commissionSupernus pharmaceuticals